Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

VISN 2 South MIRECC Contact Information

Director

René Kahn, MD, PhD

VISN 2 South MIRECC Director
Phone: 718-584-9000 ext. 5227
Email: Rene.Kahn@mssm.edu
Email2: Rene.Kahn@va.gov

Please see Dr. Kahn's full biography here
/visn3/images/Goodman.jpg

Marianne Goodman, MD

VISN 2 South Assistant Director
Phone: 718-584-9000 ext.5188
Email: Marianne.Goodman@va.gov
Marianne Goodman, MD is the assistant director of the VISN 2 South MIRECC. She directs the Dialectical Behavioral Therapy clinical and research program and suicide prevention treatment program.

 Education & Clinical Practice

/visn3/images/Kimhy.jpg

David Kimhy, PhD

Director of Education
Phone: 718-584-9000 ext. 3844
Email: David.Kimhy@mssm.edu
David Kimhy, PhD is the Director of Education for the VISN 2 MIRECC as well as an Associate Professor, the Director of the Experimental Psychopathology Laboratory, and the Program Leader for New Interventions in Schizophrenia at the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai.

Dr. Kimhy completed a 3-year NIMH-funded post-doctoral fellowship in schizophrenia research at the Department of Psychiatry at Columbia University. He also served as a Beck Institute Scholar at the Beck Institute for Cognitive Behavior Therapy. Following his post-doctoral training, he joined the Department of Psychiatry at Columbia University and The New York State Psychiatric Institute were he served as faculty for 12 years before joining Mount Sinai. Dr. Kimhy’s research funding includes numerous grants from NIMH and the National Alliance for Research of Schizophrenia and Affective Disorders (NARSAD).

/visn3/images/Landa.jpg

Yulia Landa, PsyD, MS

Fellowship Director
Phone: 718-584-9000 ext. 3703
Email: Yulia.Landa@mssm.edu
Dr. Yulia Landa conducts clinical and translational research aimed to improve treatment outcomes for patients suffering from psychosis.  Her work focuses on developing and evaluating targeted Cognitive Behavioral Therapy (CBT) interventions for the treatment and prevention of psychosis and identifying critical mechanisms (psychological and neurobiological) of their effects.  She has established individual, group and family-based CBT programs for patients experiencing delusions, paranoia and voice-hearing. To facilitate the dissemination of CBT for psychosis Dr. Landa has developed CBT for psychosis training programs and has been teaching clinicians both in the US and internationally.

Clinical & Health Services Research

/visn3/images/Dixon.jpg

Lisa Dixon, MD

Director, Clinical & Health Services Research
Phone: 718-584-9000 ext.5227
Email: DixonLi@nyspi.columbia.edu
Lisa Dixon, MD, MPH conducts health services research that focuses on improving the quality of care for persons with SMI including increasing metabolic monitoring, reducing smoking, increasing consumer-driven family involvement in care, and reducing disability among persons who are early in the course of a psychotic illness.
/visn3/images/Corcoran.jpg

Cheryl Corcoran, MD

Phone: 718-584-9000 ext.5227
Email: Cheryl.Corcoran@mssm.edu
Dr. Corcoran has expertise in schizophrenia, specifically its early stages. She has research funding to study disturbances in sensory processing, language and social cognition across stages of schizophrenia, using MRI, EEG and more recently, automated natural language processing analysis to measure semantic coherence and syntactic complexity. She has used non-invasive brain stimulation for cognitive mapping and to identify targets and circuits for therapeutic neurostimulation. Dr. Corcoran has also studied the role of stress and drug use in onset and symptom expression in schizophrenia, as well as stigma and paths to prevention and recovery.

Translational Research

/visn3/images/Haroutunian.jpg

Vahram Haroutunian, PhD

Director of Research
Phone: 718-584-9000 ext.6082
Email: Vahram.Haroutunian@mssm.edu
Vahram Haroutunian, PhD uses postmortem human brain and genetically modified mouse model systems we study the neurobiology of serious mental illness with a strong, albeit not exclusive, emphasis on schizophrenia and molecular biological and genetic techniques.
/visn3/images/Dracheva.jpg

Stella Dracheva, PhD

Phone: 718-584-9000 ext.6085
Email: Stella.Dracheva@mssm.edu
Stella Dracheva, PhD investigates the role of mRNA editing and epigenetic regulation (DNA methylation and histone modifications) in suicide and other psychiatric conditions using postmortem human brain specimens and/or animal models as well as state of the art methodologies (e.g., RNA-Seq, CHIP-Seq, Infinium 450K Methylation array).
/visn3/images/Hazlett.jpg

Erin Hazlett, PhD

Phone: 718-584-9000 ext.3701
Email: Erin.Hazlett@mssm.edu
Erin Hazlett, Ph.D. conducts multidisciplinary clinical research using neuroimaging and psychophysiological approaches. Her studies examine the neurobiology of attention and emotion processing abnormalities in schizophrenia-spectrum disorders, personality disorders, and major depressive disorder. She has received funding from the Department of Veterans Affairs, Department of Defense, National Institutes of Mental Health, and private foundations (e.g., Brain & Behavior Research Foundation). Her most recent VA Merit Award grant uses neuroimaging and psychophysiology to examine emotional processing in Veterans at low and high risk for suicide. If you are interested in finding out more about this study call (718) 584-9000 x3605 (Daniel Vaccaro, Clinical Research Assistant). Dr. Hazlett has over 140 peer-reviewed publications and book chapters, is currently a standing member of the Adult Psychopathology and Disorders of Aging (APDA) study section for NIH, and sits on the Editorial Board of the journal Psychophysiology.
/visn3/images/Roussos.jpg

Panagiotis Roussos, MD, PhD

Phone: 718-584-9000 ext.6080
Email: Panagiotis.Roussos@mssm.edu
Panos Roussos's research is focused on discerning the neurobiology of neuropsychiatric illnesses through understanding the regulation of gene expression. He applies a combination of Molecular Biology and Bioinformatics approaches to tackle these questions.
/visn3/images/Szeszko.jpg

Philip R. Szeszko, PhD

Phone: 718-584-9000 ext.5869
Email: Philip.Szeszko@va.gov
Philip R. Szeszko, Ph.D. focuses on the role of abnormal white matter in the neurobiology of psychiatric disorders and how these abnormalities may contribute to neuropsychological and functional outcome. He has received funding from the Brain and Behavior Research Foundation, Obsessive-Compulsive Foundation, American Foundation for Suicide Prevention, DANA Foundation and National Institute of Mental Health to conduct brain imaging studies in patients with psychiatric disorders. He has authored or co-authored over 100 peer-reviewed manuscripts and sits on the Editorial Boards of Progress in Neuro-psychopharmacology, Biological Psychiatry and Psychiatry Research: Neuroimaging.

Retired Staff

Larry Siever, MD

Retired, VISN 2 South MIRECC Director
Larry Siever, MD was the Chief of Psychiatry and Director of the MIRECC at the JJ Peters VAMC. Dr. Siever studied the etiology of the schizophrenia spectrum and affect and impulsive aggression regulation in serious mental illness.
/visn3/images/Byne.jpg

William Byne, MD, PhD

William Byne, MD, PhD employed a variety of postmortem histological and in vivo neuroimaging techniques to examine brain structure and function in serious mental illness and initiated a pharmacological trial in schizophrenia.
/visn3/images/Kayman.jpg

Deborah Kayman, PhD, LMSW

Phone: 718-584-9000 ext.5227
As a social worker, Dr Kayman's research priorities are to promote Veteran empowerment, safety and recovery by examining interventions to (a) prevent crises (e.g., through suicide risk assessment); (b) increase access to peer support (e.g., through new technologies); and (c) impart useful skills (e.g., for problem-solving).
/visn3/images/Levine.jpg

Bruce Levine, MD

Retired Director, Education & Clinical Practice
Phone: 718-584-9000 ext. 5204
Email: Bruce.Levine@va.gov
Bruce Levine, MD focuses on the implementation of the full spectrum of evidence based, recovery oriented practice: assessment and diagnosis, treatment partnership, psychotherapies and psychosocial interventions, and psychopharmacological treatments. 

Administrative

 Mark Levinson, Administrative Officer 
    Phone: 718-584-9000 ext.3698 
    Email: Mark.Levinson@va.gov 
Mary Corsey, Office Manager 
    Phone: 718-584-9000 ext.5227 
    Email: Mary.Corsey@va.gov 
Evelyn Padilla, Staff Assistant 
    Phone: 718-584-9000 ext.3699 
    Email: Evelyn.Padilla@va.gov 
Maureen Kilmade, Staff Assistant 
    Phone: 718-584-9000 ext.6953 
    Email: Maureen.Kilmade@va.gov 

Page Content Provider: Maureen Kilmade

Contact

VISN 2 South MIRECC Main Office
JJP VAMC Room 6A-44
718-584-9000 Ext. 5227